FDA receives letter of interest (LOI) to test specificity of molecular membrane antibodies as part of ISTAND drug development tool pilot program
PHILADELPHIA , September 7, 2022 /PRNewswire/ -- Integral Molecular, the leader in membrane protein antibody discovery, has joined the US...